DUTCH Hormone Test Interpretation Guide — Complete FM Practitioner Reference

The comprehensive reference for functional medicine practitioners — from cortisol rhythms to estrogen metabolite pathways, androgen profiles, neurotransmitters, and which panel to order for every clinical scenario.

Bookmark this page. If you order DUTCH tests in your practice, this is the guide you'll keep coming back to.

The DUTCH test (Dried Urine Test for Comprehensive Hormones) has become a cornerstone of functional endocrinology — not because it replaces serum, but because it shows what serum can't: hormone metabolites, metabolized cortisol, diurnal cortisol rhythm, estrogen detoxification pathways, and — with the Complete panel — functional markers like neurotransmitter metabolites, oxidative stress, and melatonin. This guide covers all of it.

---

Table of Contents

1. What the DUTCH Test Measures (and What It Doesn't)
2. Why DUTCH Instead of Serum? The Clinical Case
3. Understanding the Four Cortisol Patterns
4. The Cortisol Awakening Response: The Marker Most Practitioners Miss
5. Interpreting Estrogen Metabolites: 2-OH, 4-OH, 16-OH, and the 2/16 Ratio
6. Phase 1 vs. Phase 2 Estrogen Detoxification on DUTCH
7. Progesterone and Testosterone Metabolites
8. DHEA-S and Adrenal Reserve
9. OAT Markers in DUTCH Complete: Neurotransmitters, Melatonin, and Oxidative Stress
10. Perimenopause Hormone Patterns on DUTCH
11. DUTCH Complete vs. DUTCH Plus vs. Cycle Mapping: Which Panel to Order
12. How to Explain DUTCH Results to Patients
13. Clinical Decision Framework: Reading the Full Picture
14. Case Studies
15. FAQ

---

1. What the DUTCH Test Measures (and What It Doesn't) {#1-what-the-dutch-test-measures}

What exactly does DUTCH measure — and where does it fall short?

DUTCH measures urinary hormones via LC-MS/MS (liquid chromatography tandem mass spectrometry) — the gold standard methodology for steroid hormone quantification. Unlike serum, which captures a single snapshot of free and bound hormone, dried urine measures hormone metabolites: the downstream byproducts of what the body actually does with each hormone.

What's Included by Category

Category	Markers
Estrogens	Estradiol (E2), estrone (E1), estriol (E3)
Estrogen Metabolites	2-OHE1, 4-OHE1, 16α-OHE1, 2-MeOE1, 2-MeOE2
Progesterone	Pregnanediol (progesterone metabolite)
Androgens	Testosterone, DHEA-S, androsterone, etiocholanolone, 5α-DHT
Free Cortisol (Diurnal)	Morning, noon, evening, night (4 time points)
Cortisol Metabolites	THF, THE, a-THF
DUTCH Plus (add-on)	Cortisol Awakening Response — 4 salivary CAR samples
DUTCH Complete (OATs)	Neurotransmitter metabolites, melatonin (6-OHMS), 8-OHdG, B-vitamin markers, gut dysbiosis markers

What DUTCH Does NOT Measure

• Active free serum hormone levels in real time — DUTCH reflects 24-hour average output and metabolite patterns
• Thyroid hormones — TSH, T4, T3, reverse T3, antibodies require a separate serum panel
• Insulin and blood glucose dynamics
• Standard metabolic markers (CBC, CMP)

The key framing for patients and new practitioners: DUTCH doesn't replace serum labs. It adds the metabolite layer. Serum tells you what's circulating. DUTCH tells you what the body is doing with it.

---

2. Why DUTCH Instead of Serum? The Clinical Case {#2-why-dutch-vs-serum}

If I'm already ordering serum estradiol and cortisol, why add DUTCH?

Because serum and DUTCH answer fundamentally different questions. Here are the three clinical gaps that DUTCH fills that serum cannot.

1. How estrogen is being metabolized. A patient with normal serum estradiol of 80 pg/mL can still have elevated 4-hydroxyestrone (4-OHE1) — the genotoxic estrogen metabolite associated with DNA adduct formation. You'd never see this from serum alone. DUTCH maps the full metabolite picture.

2. The cortisol diurnal rhythm. A morning serum cortisol of 14 mcg/dL looks normal on paper. But if that patient's noon, evening, and night cortisol are also 14 mcg/dL — a flatline — you're looking at HPA axis exhaustion and lost diurnal rhythm. Serum catches a number. DUTCH catches a pattern.

3. Whether cortisol metabolism is efficient. Cortisol metabolites (THF + THE) reflect how quickly the body clears cortisol. Some patients show normal free cortisol with elevated metabolites — meaning rapid clearance, often tied to liver upregulation. Others show low metabolites with normal free cortisol — impaired clearance. Neither of these shows up on serum.

When to Choose DUTCH Over (or in Addition to) Serum

• Symptomatic patient with "normal range" serum hormones
• Perimenopause or menopause workup with complex symptom picture
• Fatigue, mood disruption, sleep, and weight gain that don't fit a single serum finding
• Post-HRT or BHRT monitoring — metabolites matter as much as levels
• Any clinical picture suggesting HPA axis dysregulation
• Complex neuro-endocrine cases (→ DUTCH Complete with OATs)

---

3. Understanding the Four Cortisol Patterns {#3-the-four-cortisol-patterns}

What are the main cortisol patterns I'll see on DUTCH, and what do they mean clinically?

DUTCH measures free cortisol at four time points across the day — morning, noon, evening, night — generating a diurnal curve that is the foundation of adrenal assessment. In practice, you'll see four dominant patterns.

Deep dive: Understanding Cortisol Patterns on DUTCH Tests — full clinical detail on all four patterns with treatment protocols

Pattern 1: Flat — HPA Axis Exhaustion

Cortisol is low at all four time points with minimal variation. The morning level that should be highest barely rises above the overnight reading.

The patient: Two or more years of high-stress output — demanding career, caregiving, chronic illness. Fatigue from the moment they wake up. Often cycling through caffeine and crashing. Frequently misidentified as thyroid dysfunction until the DUTCH reveals the adrenal picture.

Treatment approach: Remove stimulants. Adrenal glandular support initially. Adaptogenic herbs — ashwagandha (KSM-66 600mg/day), rhodiola rosea. B-complex plus Vitamin C. Magnesium glycinate. Enforce a 10pm bedtime and eliminate high-intensity exercise until recovery stabilizes.

Pattern 2: Elevated — Chronic Stress Response

Cortisol is high at most or all time points, particularly the evening and night values that should be near nadir.

The patient: High-achieving, anxious, sleep-onset insomnia, difficulty "shutting off." Often exercises intensely, which compounds cortisol elevation. May present with unexplained weight gain despite a clean diet.

Treatment approach: Phosphatidylserine 400–800mg in the evening to blunt nocturnal cortisol. Magnesium glycinate at night. Parasympathetic activation practices: box breathing, yoga nidra. Rule out sleep apnea — untreated OSA is a common driver of persistent nocturnal cortisol elevation.

Pattern 3: Frozen — Lost Diurnal Rhythm

Morning cortisol is normal or slightly elevated, but by noon it has collapsed and remains low through evening and night. No gradual decline — an abrupt drop.

The patient: "Fine in the morning, hits a wall after lunch." Classic type-A professional waking early, pushing through with caffeine until mid-day, then crashing by 1–2 PM.

Treatment approach: Small protein-fat snack before the noon crash. Rhodiola in the morning, ashwagandha in the evening. Gradually shift wake time later. Protect the post-noon rest window.

Pattern 4: Chaotic — Severe HPA Dysregulation

Cortisol is erratic with no predictable pattern. May be low in the morning and elevated at night, or wildly variable across collections.

The patient: Often post-trauma, post-viral (including long COVID), or in the context of multiple concurrent severe stressors. This pattern warrants a broader differential.

Treatment approach: Prioritize circadian entrainment above everything else — consistent wake time, morning sunlight, screens off by 9 PM. Low-dose ashwagandha to stabilize the rhythm. Rule out concurrent pathology: sleep apnea, thyroid disease, autoimmune conditions.

---

4. The Cortisol Awakening Response: The Marker Most Practitioners Miss {#4-cortisol-awakening-response}

What is the CAR, and why does it matter if the diurnal curve looks normal?

The Cortisol Awakening Response (CAR) is a distinct neurologically-mediated cortisol surge that occurs in the first 30–60 minutes after waking. It is separate from the diurnal curve — driven by anticipatory HPA axis activation rather than standard ACTH signaling. DUTCH Plus captures it via four salivary samples: immediately upon waking (T0), +30 min, +45 min, and +60 min.

A normal CAR represents a 50–160% rise in cortisol from waking baseline. This surge is the body's way of preparing for the demands of the day — priming immune function, memory consolidation, and metabolic readiness.

CAR Pattern	Clinical Implication
Normal (50–160% rise)	HPA axis intact; healthy anticipatory response
Blunted (<30% rise)	HPA exhaustion, low stress resilience, burnout
Exaggerated (>160% rise)	Anxiety-dominant, anticipatory hyperactivation

Why this matters: A blunted or absent CAR can confirm HPA axis exhaustion even when the diurnal free cortisol curve looks completely normal. This is the pattern behind patients who come in with severe morning fatigue, zero stress resilience, and slow recovery — yet their DUTCH Complete is "borderline." Adding the CAR via DUTCH Plus often provides the missing diagnostic resolution.

When to order DUTCH Plus: morning-specific fatigue that persists despite addressing the diurnal pattern, burnout presentations in healthcare workers or caregivers, and as a second-order test after a borderline DUTCH Complete diurnal picture.

See also: DUTCH Complete vs. DUTCH Plus: Which to Order — full CAR clinical case and ordering decision tree

---

5. Interpreting Estrogen Metabolites: 2-OH, 4-OH, 16-OH, and the 2/16 Ratio {#5-estrogen-metabolites}

What are the three estrogen hydroxylation pathways, and how do I interpret the 2/16 ratio?

This is where DUTCH delivers information that no serum panel can provide. After estradiol (E2) is produced, it undergoes hepatic Phase 1 hydroxylation via cytochrome P450 enzymes — creating three distinct metabolite streams with different biological activity and risk profiles.

Pathway	Metabolite	Profile	Clinical Notes
2-OH pathway	2-OHE1, 2-OHE2	Protective	Weakly estrogenic; anti-proliferative relative to other pathways
4-OH pathway	4-OHE1, 4-OHE2	Genotoxic	Can form DNA adducts; associated with estrogen-dependent cancer risk
16-OH pathway	16α-OHE1	Proliferative	Pro-estrogenic; promotes cell growth; elevated in some cancers

The 2/16 Ratio

Formula: 2-OHE1 ÷ 16α-OHE1
Optimal: >1.0 (ideally 2.0+)

A low 2/16 ratio means the body is routing disproportionate estrogen toward the proliferative 16α-OHE1 pathway relative to the protective 2-OHE1 pathway. This pattern correlates with estrogen dominance symptoms, higher breast tissue proliferation potential, and worsened perimenopausal presentations.

Common drivers of a low 2/16 ratio:

• High body fat (adipose aromatase drives more total estrogen production)
• Liver congestion or Phase 1/2 impairment
• COMT polymorphisms (affecting methylation of 2-OHE1)
• Chronic stress (cortisol competes for Phase 2 resources)
• Low cruciferous vegetable intake

How to improve the ratio:

• DIM (diindolylmethane) 200–400mg/day or I3C 200–400mg/day
• Broccoli sprouts (sulforaphane activates NRF2, upregulates 2-OH pathway)
• Methylated B-vitamins and magnesium to optimize COMT-driven Phase 2 methylation
• Liver support: NAC, milk thistle, soluble fiber

Deep dive: DUTCH Test Estrogen Metabolites Explained — full guide to estrogen pathway interpretation, the 4-OH pathway, COMT methylation, and clinical protocols

---

6. Phase 1 vs. Phase 2 Estrogen Detoxification on DUTCH {#6-estrogen-detoxification-phases}

What's the difference between Phase 1 and Phase 2 estrogen metabolism, and how does DUTCH show both?

DUTCH shows not just which pathway estrogens are taking, but whether Phase 2 methylation is keeping pace with Phase 1 output.

Phase 1 (Hydroxylation): CYP enzymes (CYP1A1, CYP1A2, CYP1B1) convert estrogen into hydroxylated metabolites — 2-OHE1, 4-OHE1, 16α-OHE1. High Phase 1 activity is generally manageable if Phase 2 methylation can absorb it.

Phase 2 (Methylation via COMT): COMT (catechol-O-methyltransferase) converts 2-OHE1 → 2-MeOE1 — an inert, excreted metabolite. This deactivation step is the key safety gate. If COMT is impaired — by the common Val158Met polymorphism, or by nutrient deficiencies in B2, B6, B9, B12, or magnesium — both 2-OHE1 and 4-OHE1 can accumulate and undergo oxidation to quinones, which damage DNA.

On DUTCH: Compare 2-OHE1 (unmethylated) versus 2-MeOE1 (methylated). A low 2-MeOE1 relative to 2-OHE1 signals impaired COMT methylation — a finding that changes treatment priority from "more DIM" to "fix methylation first."

Methylation bottleneck protocol:

• Methylcobalamin (B12) + L-5-MTHF (methylfolate)
• Riboflavin (B2) — often overlooked but a direct COMT cofactor
• Magnesium glycinate (COMT cofactor and general Phase 2 support)
• P-5-P (active B6) — particularly relevant if xanthurenic acid is elevated on OAT
• DIM to shift CYP balance (reduce 4-OH production at Phase 1)

---

7. Progesterone and Testosterone Metabolites {#7-progesterone-and-testosterone}

What do progesterone and testosterone metabolites tell me beyond a serum level?

Progesterone: Pregnanediol

DUTCH measures pregnanediol — the primary progesterone urinary metabolite — as the index of luteal-phase progesterone production. It also measures pregnanetriol, a 17-OH progesterone metabolite that elevates in late-cycle adrenal stress patterns.

Low pregnanediol indicates: anovulatory cycles, luteal phase deficiency, HPA axis "pregnenolone steal" (chronic cortisol demand pulling precursors away from progesterone synthesis), or perimenopause/early menopause transition.

Elevated pregnanediol with low estrogen in a patient on exogenous progesterone is an expected finding — but its clinical significance depends on whether tissue-level effects are being achieved (oral progesterone produces high pregnanediol but may behave differently from topical at the receptor level).

Testosterone Metabolites

DUTCH measures testosterone plus its downstream metabolites: androsterone, etiocholanolone, and 5α-androstanediol (a marker of 5α-reductase activity and the primary pathway through which DHT exerts tissue effects).

Clinical applications:

• Low testosterone metabolites in men with low DHEA-S → adrenal-origin androgen depletion, not primary gonadal failure
• Elevated 5α-androstanediol → high 5α-reductase activity; relevant in androgenic alopecia, PCOS with hair loss, cystic acne
• High androsterone/etiocholanolone ratio → favored androgenic pathway; clinically significant in PCOS workups

---

8. DHEA-S and Adrenal Reserve {#8-dhea-and-adrenal-reserve}

How do I use DHEA-S on DUTCH to assess adrenal reserve?

DHEA-S on DUTCH reflects overall adrenal reserve — think of it as the adrenal "bandwidth" marker. It's the most abundant adrenal steroid and a precursor to downstream sex hormones in both sexes.

Low DHEA-S is associated with the flat or frozen cortisol patterns, fatigue, low libido, poor exercise recovery, and depression. It's common over age 40 and prevalent in post-viral fatigue syndromes and post-trauma presentations.

High DHEA-S can occur in early-stage stress responses, in PCOS (often with elevated androgens and low progesterone), or as an artifact of DHEA supplementation taken too close to collection.

The Cortisol:DHEA-S Ratio

Arguably more informative than either marker alone. A high ratio — elevated cortisol with depleted DHEA-S — indicates an imbalanced HPA axis: catabolic and cortisol-dominant, with insufficient anabolic reserve. This pattern is common in burnout presentations and post-trauma.

DHEA support approach: Don't supplement DHEA without knowing the pattern first — in women especially, exogenous DHEA can convert to testosterone or estrogen in unpredictable ratios depending on tissue 5α-reductase and aromatase activity. Address root cause first (cortisol normalization, sleep, stress reduction). When supplementation is appropriate, start at 5–25mg in women and 25–50mg in men, and retest in 90 days.

---

9. OAT Markers in DUTCH Complete: Neurotransmitters, Melatonin, and Oxidative Stress {#9-oat-markers}

What does the OAT section of DUTCH Complete add that the hormone section doesn't?

This is what separates DUTCH Complete from all other hormone panels — and from DUTCH Plus. The Organic Acids Test (OAT) section elevates the assessment from a hormone test to a whole-system functional evaluation.

Neurotransmitter Metabolites

DUTCH Complete measures urinary metabolites that reflect the systemic turnover of key neurotransmitter pathways:

Metabolite	Reflects	Clinical Significance
5-HIAA	Serotonin turnover	Low = serotonin depletion; high = excess serotonin activity
VMA	Epinephrine + norepinephrine turnover	High = catecholamine excess / chronic sympathetic overdrive
HVA	Dopamine turnover	Low = dopamine depletion (fatigue, low motivation, flat affect)
Kynurenic acid / xanthurenic acid	B6 status + kynurenine pathway	Elevated = B6 deficiency; kynurenine pathway activation (relevant in depression)

Why this changes treatment: A patient presenting with "tired and wired" anxiety can have high VMA and low HVA — catecholamine excess with dopamine depletion. Treatment looks nothing like a patient with low 5-HIAA and normal VMA. The OAT section makes those distinctions explicit.

Melatonin: 6-OHMS

DUTCH Complete measures 6-hydroxymelatonin sulfate (6-OHMS) — the primary urinary melatonin metabolite. Low 6-OHMS in a patient with sleep complaints confirms melatonin insufficiency and guides dosing. It also contextualizes the cortisol picture: elevated nocturnal cortisol and low melatonin is a classic cortisol-melatonin antagonism pattern driving sleep disruption.

Supplement guidance: 0.5–3mg melatonin taken 2 hours before target sleep time. Avoid high doses (5–10mg) — they may suppress endogenous production over time.

Oxidative Stress: 8-OHdG

8-hydroxy-2'-deoxyguanosine is a urinary marker of oxidative DNA damage. Elevated 8-OHdG flags systemic oxidative stress — common in mitochondrial dysfunction, metabolic syndrome, chronic high-intensity stress with poor recovery, and significant environmental toxin burden.

Response protocol: Liposomal or IV glutathione 500–1000mg/day, NAC 600–1200mg/day, CoQ10 (ubiquinol) 200–400mg/day. Evaluate for heavy metal burden if 8-OHdG is significantly elevated without an obvious lifestyle cause.

Documenting findings this complex takes time. HANS reads DUTCH Complete results and generates structured clinical summaries built for functional medicine documentation — cutting interpretation-to-chart time significantly. See how HANS works →

---

10. Perimenopause Hormone Patterns on DUTCH {#10-perimenopause-patterns}

What does a typical perimenopausal DUTCH result look like, and how do I interpret it?

Perimenopause is the most common context for DUTCH ordering in many FM practices. The classic pattern:

Marker	Typical Finding	Significance
Estradiol (E2)	Variable — often high-normal or erratic	Anovulatory cycles drive dramatic swings
Pregnanediol	Low	Progesterone deficiency from anovulation
2-OHE1	Decreased	Liver and COMT stress reduce protective pathway
16α-OHE1	Elevated	Relative excess of proliferative metabolite
2/16 Ratio	<1.0	Unfavorable — warrants intervention
Cortisol pattern	Elevated or Frozen	HPA stress overlaps with hormonal transition
DHEA-S	Low-normal	Adrenal aging

Estrogen Dominance in Perimenopause

The perimenopausal "estrogen dominance" picture isn't always high absolute estrogen — it's usually the relative deficiency of progesterone against a backdrop of persistent or variable estrogen. DUTCH captures this balance through the estrogen/pregnanediol ratio and metabolite profiles in a way serum simply cannot.

Correlating symptoms: Heavy or irregular periods, pre-period mood swings and irritability, breast tenderness and fibrocystic changes, bloating, fluid retention, sleep disruption.

Treatment approach: Bioidentical progesterone (oral or topical) timed to the luteal phase or continuous in late perimenopause. DIM plus methylfolate to improve the 2/16 ratio. Adaptogen support for concurrent cortisol elevation. Liver support (NAC, milk thistle) to enhance Phase 2 clearance.

Deep dive: DUTCH Test Estrogen Metabolites Explained — includes a full perimenopausal case example

---

11. DUTCH Complete vs. DUTCH Plus vs. Cycle Mapping: Which Panel to Order {#11-panel-selection}

How do I decide which DUTCH panel to order for each patient?

This is the most common decision point for practitioners new to DUTCH. Here's the short version:

Patient Presentation	Recommended Panel
First hormone workup; perimenopausal; general fatigue/mood/libido	DUTCH Complete
Morning fatigue + poor resilience + HPA burnout suspected	DUTCH Plus
Irregular cycles, infertility, luteal phase deficiency	DUTCH Cycle Mapping
Complex, treatment-resistant case with neuro/gut/mood symptoms	DUTCH Complete (OATs are essential)
Follow-up after DUTCH Complete showed borderline diurnal cortisol	DUTCH Plus

DUTCH Complete vs. DUTCH Plus

DUTCH Plus equals DUTCH Complete plus four salivary Cortisol Awakening Response samples. The CAR provides additional diagnostic resolution for the morning cortisol window. If morning fatigue is a primary complaint and the diurnal pattern on DUTCH Complete is borderline, upgrading to DUTCH Plus often reveals a blunted CAR that confirms HPA axis exhaustion — and changes the treatment protocol.

Rule of thumb: Start with DUTCH Complete for most patients. Move to DUTCH Plus when morning-specific HPA axis questions persist after initial workup.

DUTCH Cycle Mapping: A Different Test Entirely

DUTCH Cycle Mapping is a 9-collection test that maps estrogen and progesterone throughout the full menstrual cycle. It does not include androgens, cortisol rhythm, or OATs. It answers one specific question: what are the cyclical hormone dynamics doing?

Order Cycle Mapping for: irregular cycles, suspected anovulation, luteal phase deficiency, unexplained infertility in a cycling patient, hormonally-driven migraines, and post-OCP recovery monitoring.

See also: DUTCH Complete vs. DUTCH Plus: Which to Order — full panel comparison table, CAR decision tree, and ordering workflow

---

12. How to Explain DUTCH Results to Patients {#12-patient-communication}

How do I communicate a complex DUTCH result in a 30-minute appointment without losing the patient?

DUTCH gives you a map. Your job is to tell the patient a story — what their body has been doing with hormones, not just what levels are. Most patients can follow that narrative immediately if you anchor it to their symptoms.

Three core messages that land consistently:

1. "Here's your cortisol story." Show them the diurnal curve. Point to where cortisol should be high (morning) and low (night). Then show their actual curve. In most cases they'll immediately recognize their symptoms in the shape of the line — "Oh, that's exactly why I crash after lunch."

2. "Here's how you're processing estrogen." Keep it simple: "Your body is sending too much estrogen down the proliferative pathway instead of the protective one. This is likely driving your breast tenderness and heavy periods. Here's the plan."

3. "Here's what this tells us about your brain chemistry and overall stress load." If you ordered DUTCH Complete, the OAT markers give you an opening to connect neurotransmitter patterns to mood, motivation, and sleep complaints the patient has often been describing for years without a framework.

Principles: Always lead with symptoms first — "This explains why you feel tired in the morning." Limit to three action items per visit; prioritize by root cause. Use the visual DUTCH report — patients understand graphs far better than reference range tables.

---

13. Clinical Decision Framework: Reading the Full Picture {#13-clinical-framework}

What's the right order to interpret DUTCH markers so I don't miss the systemic picture?

Experienced DUTCH interpreters don't evaluate markers in isolation — they build a picture, system by system. Here's the sequence used in practice.

Step 1: Start with the stress axis. The diurnal cortisol curve — and CAR if ordered — goes first. Every downstream hormone is affected by cortisol output. Elevated cortisol suppresses thyroid conversion, depletes DHEA-S, impairs progesterone synthesis via pregnenolone steal, and disrupts sleep. If you don't understand the cortisol picture first, you'll misread everything else.

Key questions: Is the rhythm intact? Is DHEA-S proportionate? What is the cortisol:DHEA-S ratio?

Step 2: Assess the estrogen metabolite profile. Once the stress axis is understood, evaluate the estrogen picture: 2/16 ratio, 4-OHE1 elevation, and COMT methylation throughput (2-MeOE1 relative to 2-OHE1).

Step 3: Evaluate progesterone and androgens. Is pregnanediol appropriate for cycle phase or menopausal status? Is testosterone/DHEA-S depleted in a way that reflects adrenal-androgen suppression? Are 5α-reductase metabolites elevated in ways that explain androgenic symptoms?

Step 4: Review OAT markers (DUTCH Complete only). The OAT section often provides the final explanatory piece for complex, treatment-resistant cases. Neurotransmitter patterns, 8-OHdG, and melatonin frequently connect the dots between endocrine findings and behavioral or cognitive symptoms.

Step 5: Build the root cause narrative. This is what separates interpretation from reporting.

Here's an example of what that synthesis sounds like:

"This patient has elevated cortisol in a frozen pattern driving progesterone depletion via pregnenolone steal — explaining her perimenopausal estrogen dominance symptoms. Her elevated 4-OHE1 with impaired COMT methylation creates a genotoxic estrogen accumulation risk. Elevated VMA on OAT confirms catecholamine excess — that's her 3 AM waking and anxiety. 8-OHdG is elevated: this is an oxidative stress case, not just a hormone case."

That level of synthesis is what DUTCH enables. It's also what most practitioners find hardest to do efficiently under appointment-time pressure — which is why having a structured interpretation framework matters.

→ Part of the Lab Interpretation Hub: the complete functional medicine lab reference for FM practitioners.

---

14. Case Studies {#14-case-studies}

Case 1: 44-Year-Old Female — Perimenopause + Burnout Overlap

Chief complaint: Fatigue, irregular heavy periods, 15-pound weight gain over 18 months, sleep-onset insomnia, wakes at 3 AM.

DUTCH Complete Results:

• Cortisol pattern: Frozen (normal morning, crashes at noon, flat through night)
• DHEA-S: Low-normal
• Estradiol: High-normal
• Pregnanediol: Low (anovulatory cycle captured)
• 2/16 Ratio: 0.72 (below optimal 1.0)
• 4-OHE1: Elevated
• 2-MeOE1/2-OHE1: Low (impaired COMT methylation)
• VMA (OAT): Elevated
• 8-OHdG: Elevated
• Melatonin (6-OHMS): Low

Interpretation: Frozen cortisol pattern indicates HPA axis dysfunction in the late-stress/pre-burnout phase. Anovulatory progesterone deficiency is driving relative estrogen dominance. Elevated 4-OHE1 with impaired COMT methylation creates a genotoxic estrogen metabolite risk — this is not just a symptomatic estrogen dominance picture. Elevated VMA confirms catecholamine excess, explaining the 3 AM waking and inability to fall back asleep. Low melatonin plus elevated cortisol is classic cortisol-melatonin antagonism.

Protocol priorities:

1. Adrenal first: Phosphatidylserine 400mg PM, ashwagandha KSM-66 600mg, Vitamin C 1g/day
2. Progesterone support: Bioidentical progesterone 100mg oral at night (secondary benefit: PM cortisol modulation)
3. Estrogen pathway: DIM 200mg + methylated B-complex (riboflavin, P-5-P, methylfolate, methyl-B12)
4. Oxidative stress: NAC 600mg + liposomal glutathione 500mg
5. Sleep: Melatonin 0.5mg 2 hours before sleep + magnesium glycinate 400mg at night
6. Lifestyle: Screens off at 9 PM, consistent 7 AM wake time, eliminate caffeine

---

Case 2: 38-Year-Old Male — Fatigue + Low Libido + Suspected Testosterone Deficiency

Chief complaint: Low energy since his mid-30s, declining libido, difficulty building muscle despite consistent training, mild depression.

DUTCH Complete Results:

• Testosterone: Low-normal
• DHEA-S: Low
• Cortisol pattern: Elevated (all four time points high-normal to elevated)
• 5α-androstanediol: Low (low DHT activity despite adequate free T)
• HVA (OAT): Low
• 5-HIAA (OAT): Low
• VMA (OAT): Elevated

Interpretation: This is a textbook high-cortisol androgen suppression pattern — not primary testicular failure. Elevated cortisol is suppressing LH-driven testosterone production centrally while also competing with DHEA conversion toward androgens. Low HVA plus low 5-HIAA confirms dopamine and serotonin depletion, which explains the depression and motivational flatness. Elevated VMA confirms sympathetic overdrive as the underlying driver. Starting testosterone replacement here without addressing the cortisol pattern would be premature.

Protocol priorities:

1. Cortisol normalization first: Phosphatidylserine 800mg/day (400mg AM, 400mg PM), magnesium glycinate 400mg PM
2. DHEA support: DHEA 25mg AM; retest at 90 days
3. Dopamine precursors: L-tyrosine 500–1000mg AM, P-5-P 50mg, zinc 30mg
4. Serotonin support: 5-HTP 50–100mg PM; tryptophan-rich evening meals
5. Exercise: Reduce training volume temporarily; prioritize sleep and recovery before resuming intensity

---

15. FAQ {#15-faq}

Q: Is the DUTCH test accurate for patients on HRT or BHRT?

Yes — with important caveats. DUTCH can monitor patients on hormone replacement, but interpretation requires knowing the form of hormones in use. Oral estradiol and progesterone produce dramatically different urinary metabolite profiles than topical (transdermal or vaginal) forms. Oral progesterone, for example, produces high pregnanediol but may not reflect tissue-level effects the same way transdermal does. Always collect under standardized conditions: same point in cycle if applicable, same time relative to hormone application.

Q: When in the menstrual cycle should a DUTCH test be collected?

For cycling women, the standard collection window is days 19–22 of a 28-day cycle (mid-luteal phase). This is when progesterone peaks — the optimal window to assess luteal adequacy and capture estrogen/progesterone balance simultaneously. For irregular cycles, aim for 7–9 days before the expected next period. For perimenopausal or postmenopausal women not on HRT, collection can be done any day.

Q: Can I use DUTCH to test male patients?

Absolutely. DUTCH Complete is highly applicable for men presenting with fatigue plus low libido (testosterone/DHEA-S pattern), estrogen-related symptoms such as gynecomastia or mood issues (DUTCH shows aromatization metabolites), HPA axis assessment, and testosterone replacement therapy monitoring. The 4-OHE1 pathway is clinically relevant in men with elevated estradiol — not just a female concern.

Q: Does the DUTCH test include thyroid markers?

No. DUTCH does not include thyroid hormones — TSH, free T4, free T3, reverse T3, or thyroid antibodies require a separate serum panel. Most functional medicine practitioners pair DUTCH with a comprehensive thyroid panel and fasting metabolic labs to complete the endocrine picture.

Q: What's the difference between DUTCH reference ranges and functional optimal ranges?

A critical distinction for FM interpretation. DUTCH reference ranges are based on population norms — meaning a result can be "within reference range" and still represent suboptimal function. Functional medicine interpretation looks for patterns and relative deviations within the normal range, not just flagged out-of-range values. Always correlate with clinical presentation. Reference ranges are a starting point, not an endpoint.

Q: Can the DUTCH test replace a serum hormone panel?

No — and it shouldn't. Serum and DUTCH answer different questions. Serum is appropriate for initial hormone screening (often insurance-covered), FSH/LH ratio assessment, thyroid evaluation, IGF-1, insulin, fasting glucose, and inflammatory markers. DUTCH is appropriate for hormone metabolite profiling, HPA axis pattern recognition, estrogen pathway assessment, and neurotransmitter functional status (Complete only). The most complete workup in functional medicine uses both.

Q: How should I document DUTCH test interpretation efficiently in my practice?

Documenting DUTCH results in SOAP notes typically takes 20–40 minutes per patient — DUTCH reports are dense. HANS (the AI-native EMR built for functional medicine) reads DUTCH reports and generates structured clinical summaries, protocol suggestions, and documentation-ready interpretations, cutting that time significantly. It's one of the most common time-savings practitioners report in their first 90 days on the platform.

---

Citations

1. PMID 26563991 — Stalder T, et al. (2016). Assessment of the cortisol awakening response: Expert consensus guidelines. Psychoneuroendocrinology, 63:414–432.
2. PMID 22812714 — Inder WJ, et al. (2012). Measurement of salivary cortisol in 2012. Clin Endocrinol (Oxf), 77(5):645–651.
3. PMID 19616272 — Keevil BG, et al. (2009). Measurement of estrogen metabolites by mass spectrometry. Ann Clin Biochem, 46(Pt 5):387–395.
4. PMID 24898176 — Dutheil F, et al. (2014). DHEAS as a biomarker of stress. Psychoneuroendocrinology, 47:181–199.
5. PMID 17853059 — Jessop DS, Turner-Cobb JM. (2008). Measurement and meaning of salivary cortisol. Stress, 11(1):1–14.
6. PMID 21339936 — Muti P, et al. (2011). Estrogen metabolite ratio: Is the 2-hydroxyestrone to 16α-hydroxyestrone ratio predictive for breast cancer? J Nutr, 141(11):2018S–2023S. (CYP1A1/CYP1B1 differential hydroxylation; 2/16 ratio and breast cell proliferation.)
7. PMID 23039364 — Jiang J, et al. (2012). Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis. Diagn Pathol, 7:136. (56 studies, 34,358 cases — COMT-mediated O-methylation of catechol estrogens; mixed association with breast cancer risk; supports COMT's role in estrogen detoxification pathway.)

---

CTA

DUTCH reports are dense. Interpreting and documenting them takes 20–40 minutes per patient. HANS reads DUTCH results with you — AI-assisted interpretation built for functional medicine. See how HANS cuts documentation time in half → HANS for FM Practitioners

---